ZAVIS Leads
DashboardLeadsOutreachEmail LeadsEmailsICPSettings
ZAVIS Leads
DashboardLeadsOutreachEmail LeadsEmailsICPSettings

Dr Rahul Singh Amritraj

HIGHIndiaapify

Chief Executive Officer | Centre for Medical Innovation, GIMS (Govt. of UP, Sec 8 Company) | AI in Healthcare & Medical Devices | Startup Ecosystem Builder | Ex-Resident Doctor | Alumni- FMS University of Delhi

GIMS Centre for Medical InnovationNew Delhi, Delhi, India
40
Rank

New India lead: Dr Rahul Singh Amritraj

Chief Executive Officer | Centre for Medical Innovation, GIMS (Govt. of UP, Sec 8 Company) | AI in Healthcare & Medical Devices | Startup Ecosystem Builder | Ex-Resident Doctor | Alumni- FMS University of Delhi — New Delhi, Delhi, India. Clinic: 40, Partner: 85.

High-priority India lead: Dr Rahul Singh Amritraj

Dr Rahul Singh Amritraj scored 85/100 with 0 engagements.

Suggested outreach:

Hi Dr. Amritraj, I came across your profile and was impressed by your work at the Centre for Medical Innovation at GIMS - it's exciting to see government initiatives driving healthcare innovation in UP. As someone bridging clinical practice with AI and medical devices, I'm curious about the biggest challenges you're seeing healthcare providers face when implementing new patient engagement technologies. Would love to hear your perspective on what's working (or not working) in the current ecosystem.

AI Scores

Clinic
40
Partner
85
Density
25
Recency
0
Intent
0

Intent Pattern

i
One-timetrajectory
0 signals
0 high-intent notes
0 sources
0d since last

Pipeline

Current: New

Campaigns

No active campaigns

Cold Email

Activity Timeline

●
PipelineNEWApr 3, 2026
★
DiscoveredapifyApr 3, 2026

AI Analysis

CEO of medical innovation center in Delhi with strong AI in Healthcare focus and startup ecosystem building background. High sales partner potential due to leadership role in health tech innovation space and likely connections to EMR/health IT companies. Lower clinic lead score as this is an innovation center rather than direct patient care facility. High priority due to strategic position in Indian healthcare innovation ecosystem and potential partnership opportunities.